These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33085959)

  • 1. Health Technology Assessment and Health Care Reimbursement in the European Union: Permissive Dissensus and the Limits of Harmonization through the Backdoor.
    Löblová O
    J Health Polit Policy Law; 2021 Feb; 46(1):117-145. PubMed ID: 33085959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disagreement on cancer drug decisions in Europe.
    Maynou L; Cairns J
    Int J Technol Assess Health Care; 2020 Jun; 36(3):232-238. PubMed ID: 32538341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of health technology assessment reports on decision making in Austria.
    Zechmeister I; Schumacher I
    Int J Technol Assess Health Care; 2012 Jan; 28(1):77-84. PubMed ID: 22233544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing Use of Health Technology Assessment in Pharmaceutical Policy among Earlier and More Recent Adopters in the European Union.
    Beletsi A; Koutrafouri V; Karampli E; Pavi E
    Value Health Reg Issues; 2018 Sep; 16():81-91. PubMed ID: 30316029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is driving HTA decision-making? Evidence from cancer drug reimbursement decisions from 6 European countries.
    Maynou L; Cairns J
    Health Policy; 2019 Feb; 123(2):130-139. PubMed ID: 30477736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking the Regulatory and Reimbursement Processes for Medical Devices: The Need for Integrated Assessments.
    Ciani O; Wilcher B; van Giessen A; Taylor RS
    Health Econ; 2017 Feb; 26 Suppl 1():13-29. PubMed ID: 28139087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INTRODUCTION OF HEALTH TECHNOLOGY ASSESSMENT FOR MEDICINES IN SLOVAKIA.
    Tesar T; Hloska A; Wawruch M; Lehocka L; Snopkova M; Masarykova L
    Int J Technol Assess Health Care; 2017 Jan; 33(3):345-349. PubMed ID: 28434416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Technology Assessment (HTA) and Access Policies.
    Stühlinger V
    Eur J Health Law; 2020 May; 27(3):274-289. PubMed ID: 33652403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harmonization of evidence requirements for health technology assessment in reimbursement decision making.
    Hutton J; Trueman P; Facey K
    Int J Technol Assess Health Care; 2008; 24(4):511-7. PubMed ID: 18828948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies.
    Bloem LT; Vreman RA; Peeters NWL; Hoekman J; van der Elst ME; Leufkens HGM; Klungel OH; Goettsch WG; Mantel-Teeuwisse AK
    Clin Transl Sci; 2021 Jul; 14(4):1566-1577. PubMed ID: 33786991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transferability of health technology assessment: the European perspective with focus on central and Eastern European countries.
    Németh B; Goettsch W; Kristensen FB; Piniazhko O; Huić M; Tesař T; Atanasijevic D; Lipska I; Kaló Z
    Expert Rev Pharmacoecon Outcomes Res; 2020 Aug; 20(4):321-330. PubMed ID: 32500749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health technology assessment, value-based decision making, and innovation.
    Henshall C; Schuller T;
    Int J Technol Assess Health Care; 2013 Oct; 29(4):353-9. PubMed ID: 23845404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health technology assessment in Saudi Arabia.
    Al-Aqeel S
    Expert Rev Pharmacoecon Outcomes Res; 2018 Aug; 18(4):393-402. PubMed ID: 29733227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health technology assessment of medical devices: a survey of non-European union agencies.
    Ciani O; Wilcher B; Blankart CR; Hatz M; Rupel VP; Erker RS; Varabyova Y; Taylor RS
    Int J Technol Assess Health Care; 2015 Jan; 31(3):154-65. PubMed ID: 26044729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA.
    Vella Bonanno P; Bucsics A; Simoens S; Martin AP; Oortwijn W; Gulbinovič J; Rothe C; Timoney A; Ferrario A; Gad M; Salem A; Hoxha I; Sauermann R; Kamusheva M; Dimitrova M; Petrova G; Laius O; Selke G; Kourafalos V; Yfantopoulos J; Magnusson E; Joppi R; Jakupi A; Bochenek T; Wladysiuk M; Furtado C; Marković-Peković V; Mardare I; Meshkov D; Fürst J; Tomek D; Cortadellas MO; Zara C; Haycox A; Campbell S; Godman B
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):251-261. PubMed ID: 30696372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium.
    Van Wilder P; Pirson M; Dupont A
    Eur J Clin Pharmacol; 2019 Jul; 75(7):895-900. PubMed ID: 30877328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of archetypes for non-ranking classification and comparison of European National Health Technology Assessment systems.
    Allen N; Pichler F; Wang T; Patel S; Salek S
    Health Policy; 2013 Dec; 113(3):305-12. PubMed ID: 24176288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Policy developments of health technology assessment in the European Union].
    Baran-Kooiker A; Czech M; Hołownia-Voloskova M
    Postepy Biochem; 2019 Nov; 65(4):319-321. PubMed ID: 31945287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland.
    Allen N; Walker SR; Liberti L; Salek S
    Value Health; 2017 Mar; 20(3):320-328. PubMed ID: 28292476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.